Judith Carla Sophie Holtjer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Judith Carla Sophie Holtjer has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Laura Houweling
Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands; Dept. of Pulmonary Medicine, Amsterdam UMC, Amsterdam, the Netherlands
6 shared publications - Anke-Hilse Maitland-Van der Zee
Department of Pulmonary Medicine, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands
5 shared publications - George Stanley Downward
Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
4 shared publications L.D. Bloemsma
Dept. of Pulmonary Medicine, Amsterdam UMC, Amsterdam, the Netherlands
4 shared publicationsG.S. Downward
Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
3 shared publicationsR.C.H. Vermeulen
Department of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
3 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Environmental Research
- Vol. 310 (Pt 1) , 125843
Environmental factors associated with long COVID severity: A lifelines cohort analysis
- 15 October 2026
- Published by Elsevier in Environmental Research
- Vol. 310 (Pt 1) , 125843
Open AccessEnvironmental factors associated with long COVID severity: A lifelines cohort analysis
- 27 March 2026
- Published by Utrecht University Library
Invisible Burdens: Environmental Determinants of Respiratory and Post-COVID Health
Chronic lung diseases and long COVID impose a substantial health burden and are not fully explained by genetics, highlighting the importance of environmental factors, which remain underexplored. As long COVID is a newly recognized condition, further research is urgently needed to understand its mechanisms and identify effective prevention and treatment strategies. This thesis aimed to: (1) provide an overview of modifiable risk factors for chronic obstructive pulmonary disease (COPD) and adult-onset asthma; (2) evaluate a low-cost air pollution sensor; (3) assess differences between personal and residential PM2.5 exposure in a long COVID population; and (4) investigate associations between the external exposome and subjective long COVID severity. These objectives were addressed through an umbrella review, primary data collection in the Precision Medicine for More Oxygen (P4O2) COVID-19 cohort (typically severe cases), analysis of the Lifelines COVID-19 cohort (generally milder cases), and use of EXPANSE and national CBS exposure data. Analytical approaches included traditional and penalized regression, as well as Bayesian models. Chapter 2 identified both shared and distinct modifiable risk factors for COPD and adult-onset asthma. Asthma-specific factors included PM10 exposure and occupational exposure to cleaning products, while COPD-specific factors included PM2.5 and occupational dust. Shared risk factors included low birthweight, smoking, and ambient air pollution. Some factors showed opposite effects, such as body mass index (BMI), where higher BMI increased asthma risk but lower BMI increased COPD risk, underscoring the need to distinguish between the conditions in prevention strategies. Chapter 3 evaluated a low-cost PM2.5 sensor in the P4O2 cohort. Agreement with regulatory monitors was stronger for daily than hourly data, particularly during daylight hours (r=0.88). Variability between sensors exceeded that between sensors and regulatory stations, and performance was influenced by placement, traffic, humidity, and proximity to monitoring stations. Chapter 4 compared personal and residential PM2.5 exposure, finding higher personal exposure levels and weak-to-moderate correlations (r=0.27 overall; r=0.39 within individuals). Tobacco smoke and fireplaces were key contributors to discrepancies, highlighting the importance of measurement level. Chapters 5 and 6 examined associations between the external exposome and long COVID severity. In the P4O2 cohort, higher population density was associated with worse fatigue, while greater distance to blue space was linked to poorer quality of life (QoL), though effect sizes were small. In the Lifelines cohort, analyses stratified by sex showed that males experienced associations between low neighborhood income and worse fatigue, and greater distance to blue space and poorer QoL; no consistent associations were found in females. Results varied across analyses, indicating population-specific effects. Chapter 7 synthesizes these findings, emphasizing the role of environmental factors in respiratory health and the utility of low-cost sensors. However, environmental influences on long COVID remain complex and sometimes inconsistent. While some associations, such as those involving blue space, were observed, overall evidence was limited. Further research across diverse populations is needed. This work contributes to understanding environmental influences on chronic disease and long COVID, and may help guide future research and policy.
- 27 March 2026
- Published by Utrecht University Library
Invisible Burdens: Environmental Determinants of Respiratory and Post-COVID Health
Chronic lung diseases and long COVID impose a substantial health burden and are not fully explained by genetics, highlighting the importance of environmental factors, which remain underexplored. As long COVID is a newly recognized condition, further research is urgently needed to understand its mechanisms and identify effective prevention and treatment strategies. This thesis aimed to: (1) provide an overview of modifiable risk factors for chronic obstructive pulmonary disease (COPD) and adult-onset asthma; (2) evaluate a low-cost air pollution sensor; (3) assess differences between personal and residential PM2.5 exposure in a long COVID population; and (4) investigate associations between the external exposome and subjective long COVID severity. These objectives were addressed through an umbrella review, primary data collection in the Precision Medicine for More Oxygen (P4O2) COVID-19 cohort (typically severe cases), analysis of the Lifelines COVID-19 cohort (generally milder cases), and use of EXPANSE and national CBS exposure data. Analytical approaches included traditional and penalized regression, as well as Bayesian models. Chapter 2 identified both shared and distinct modifiable risk factors for COPD and adult-onset asthma. Asthma-specific factors included PM10 exposure and occupational exposure to cleaning products, while COPD-specific factors included PM2.5 and occupational dust. Shared risk factors included low birthweight, smoking, and ambient air pollution. Some factors showed opposite effects, such as body mass index (BMI), where higher BMI increased asthma risk but lower BMI increased COPD risk, underscoring the need to distinguish between the conditions in prevention strategies. Chapter 3 evaluated a low-cost PM2.5 sensor in the P4O2 cohort. Agreement with regulatory monitors was stronger for daily than hourly data, particularly during daylight hours (r=0.88). Variability between sensors exceeded that between sensors and regulatory stations, and performance was influenced by placement, traffic, humidity, and proximity to monitoring stations. Chapter 4 compared personal and residential PM2.5 exposure, finding higher personal exposure levels and weak-to-moderate correlations (r=0.27 overall; r=0.39 within individuals). Tobacco smoke and fireplaces were key contributors to discrepancies, highlighting the importance of measurement level. Chapters 5 and 6 examined associations between the external exposome and long COVID severity. In the P4O2 cohort, higher population density was associated with worse fatigue, while greater distance to blue space was linked to poorer quality of life (QoL), though effect sizes were small. In the Lifelines cohort, analyses stratified by sex showed that males experienced associations between low neighborhood income and worse fatigue, and greater distance to blue space and poorer QoL; no consistent associations were found in females. Results varied across analyses, indicating population-specific effects. Chapter 7 synthesizes these findings, emphasizing the role of environmental factors in respiratory health and the utility of low-cost sensors. However, environmental influences on long COVID remain complex and sometimes inconsistent. While some associations, such as those involving blue space, were observed, overall evidence was limited. Further research across diverse populations is needed. This work contributes to understanding environmental influences on chronic disease and long COVID, and may help guide future research and policy.
- Open Access
- 20 September 2025
- Published by Springer Nature in Air Quality, Atmosphere & Health
- Vol. 18 (10) , 3137-3149
Measurement variability in residential PM2.5: an evaluation of a low-cost sensor in the Netherlands
Accurate residential air quality assessment is crucial for studying health risks, evaluating local mitigation measures, and empowering citizens. Low-cost-sensors (LCS) have gained popularity for enhancing monitoring coverage and providing individuals with air quality measurement tools. This study examines the added value of a low-cost sensor in estimating residential fine particulate matter (PM 2.5 ) concentrations in the Netherlands. We employed a real-time Sensirion SPS30 dust sensor to monitor residential PM 2.5 concentrations. 73 sensors were deployed outdoors at participants’ residences with an average measurement time of 131 days. Data from LCS were compared with that of regulatory stations, using hourly and daily averages for comparison. Spatial variability of sensor measurements was assessed, and determinants were explored that explain potential differences between PM 2.5 concentrations from regulatory stations and LCS measurements. After data cleaning, 95.7% of measurements were retained. Meteorological factors did not impact sensor performance. The mean Pearson temporal correlation between the LCS and regulatory network was 0.75 for hourly and 0.88 for daily PM 2.5 averages. The average difference ranged from − 0.17 to 0.63 µg/m 3 , and the average absolute difference ranged from 2.42 to 4.50 µg/m 3 . Spatial variability of LCS-based average concentrations at similar locations was larger than that of regulatory stations. LCS measuring direction, traffic intensity, humidity, LCS readings, and distance to nearest background station had a significant effect on the difference between sensor and regulatory station concentrations. This study demonstrates that PM 2.5 can be accurately measured over extended periods using LCS, offering a dynamic, high-quality perspective on air quality, recording variations that regulatory stations and predictive air quality models may overlook.
- 20 September 2025
- Published by Springer Nature in Air Quality, Atmosphere & Health
- Vol. 18 (10) , 3137-3149
Open AccessMeasurement variability in residential PM2.5: an evaluation of a low-cost sensor in the Netherlands
Accurate residential air quality assessment is crucial for studying health risks, evaluating local mitigation measures, and empowering citizens. Low-cost-sensors (LCS) have gained popularity for enhancing monitoring coverage and providing individuals with air quality measurement tools. This study examines the added value of a low-cost sensor in estimating residential fine particulate matter (PM 2.5 ) concentrations in the Netherlands. We employed a real-time Sensirion SPS30 dust sensor to monitor residential PM 2.5 concentrations. 73 sensors were deployed outdoors at participants’ residences with an average measurement time of 131 days. Data from LCS were compared with that of regulatory stations, using hourly and daily averages for comparison. Spatial variability of sensor measurements was assessed, and determinants were explored that explain potential differences between PM 2.5 concentrations from regulatory stations and LCS measurements. After data cleaning, 95.7% of measurements were retained. Meteorological factors did not impact sensor performance. The mean Pearson temporal correlation between the LCS and regulatory network was 0.75 for hourly and 0.88 for daily PM 2.5 averages. The average difference ranged from − 0.17 to 0.63 µg/m 3 , and the average absolute difference ranged from 2.42 to 4.50 µg/m 3 . Spatial variability of LCS-based average concentrations at similar locations was larger than that of regulatory stations. LCS measuring direction, traffic intensity, humidity, LCS readings, and distance to nearest background station had a significant effect on the difference between sensor and regulatory station concentrations. This study demonstrates that PM 2.5 can be accurately measured over extended periods using LCS, offering a dynamic, high-quality perspective on air quality, recording variations that regulatory stations and predictive air quality models may overlook.
- Open Access
- 13 September 2025
- Published by Elsevier in Environmental Research
- Vol. 286 (Pt 2) , 122860
Defining a long COVID ‘expotype’ within the P4O2 COVID-19 study
- 13 September 2025
- Published by Elsevier in Environmental Research
- Vol. 286 (Pt 2) , 122860
Open AccessDefining a long COVID ‘expotype’ within the P4O2 COVID-19 study
- Open Access
- 4 September 2025
- Published by Elsevier in Environmental Research
- Vol. 286 (Pt 1) , 122707
Air pollution and long COVID: association with pulmonary function and radiological abnormalities 3–15 months post-COVID
- 4 September 2025
- Published by Elsevier in Environmental Research
- Vol. 286 (Pt 1) , 122707
Open AccessAir pollution and long COVID: association with pulmonary function and radiological abnormalities 3–15 months post-COVID
- Open Access
- 26 June 2025
- Published by Elsevier in Environmental Advances
- Vol. 21
Assessment of personal and residential outdoor fine particulate matter exposure using low-cost sensors in a long-Covid patient population
- 26 June 2025
- Published by Elsevier in Environmental Advances
- Vol. 21
Open AccessAssessment of personal and residential outdoor fine particulate matter exposure using low-cost sensors in a long-Covid patient population
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA2195
Defining a long COVID ‘expotype’ within the P4O2 COVID-19 study
Introduction: Long COVID is estimated to affect at least 10% of COVID patients, with fatigue being a common complaint. The external exposome has been associated with COVID severity, however its association with long COVID remains underexplored. This study aims to identify possible exposome phenotypes (‘expotypes’) related to long COVID. Method The P4O2 COVID-19 study consists of long COVID patients in the Netherlands and assessed a range of factors and symptoms at 3-6 months post-infection. Fatigue, assessed by the Fatigue Severity Scale (FSS), was used as an indicator of long COVID severity with scores of 4 or more being considered as “positive” for fatigue. The external exposome included factors related to for example air pollution, the food environment, and green space. We performed univariate logistic regression models and a multivariable penalized model (Lasso). Preliminary results Of the 95 participants, only complete cases were included (n=78). Of these, 58 had a FSS score of ≥4. All models were adjusted for age, BMI, and sex. Univariable logistic regression found none of the variables to improve model fit after adjusting for confounders, determined by AIC values, but walkability provided the best estimation (odds ratio (OR)[95%confidence interval(95%CI)1.12[−0.10;0.35]). Multivariable models showed no improved fit either, with a model including PM2.5 (2.06[−0.24;1.77]), NO2(0.86[−0.32;0.00]), and walkability (1.22[−0.05;0.50]) providing the best fit. None of the variables were selected in LASSO regression models. Discussion The external exposome could be associated with fatigue severity in long COVID patients. Prevention strategies and urban planning could take these associations into account top optimize health.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA2195
Defining a long COVID ‘expotype’ within the P4O2 COVID-19 study
Introduction: Long COVID is estimated to affect at least 10% of COVID patients, with fatigue being a common complaint. The external exposome has been associated with COVID severity, however its association with long COVID remains underexplored. This study aims to identify possible exposome phenotypes (‘expotypes’) related to long COVID. Method The P4O2 COVID-19 study consists of long COVID patients in the Netherlands and assessed a range of factors and symptoms at 3-6 months post-infection. Fatigue, assessed by the Fatigue Severity Scale (FSS), was used as an indicator of long COVID severity with scores of 4 or more being considered as “positive” for fatigue. The external exposome included factors related to for example air pollution, the food environment, and green space. We performed univariate logistic regression models and a multivariable penalized model (Lasso). Preliminary results Of the 95 participants, only complete cases were included (n=78). Of these, 58 had a FSS score of ≥4. All models were adjusted for age, BMI, and sex. Univariable logistic regression found none of the variables to improve model fit after adjusting for confounders, determined by AIC values, but walkability provided the best estimation (odds ratio (OR)[95%confidence interval(95%CI)1.12[−0.10;0.35]). Multivariable models showed no improved fit either, with a model including PM2.5 (2.06[−0.24;1.77]), NO2(0.86[−0.32;0.00]), and walkability (1.22[−0.05;0.50]) providing the best fit. None of the variables were selected in LASSO regression models. Discussion The external exposome could be associated with fatigue severity in long COVID patients. Prevention strategies and urban planning could take these associations into account top optimize health.
- Open Access
- 16 October 2023
- Published by Elsevier in Environmental Research
- Vol. 240 (Pt 2) , 117351
The effect of the urban exposome on COVID-19 health outcomes: A systematic review and meta-analysis
- 16 October 2023
- Published by Elsevier in Environmental Research
- Vol. 240 (Pt 2) , 117351
Open AccessThe effect of the urban exposome on COVID-19 health outcomes: A systematic review and meta-analysis
- Open Access
- 28 June 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (7) , 1060
Precision Medicine for More Oxygen (P4O2)—Study Design and First Results of the Long COVID-19 Extension
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has led to the death of almost 7 million people, however, with a cumulative incidence of 0.76 billion, most people survive COVID-19. Several studies indicate that the acute phase of COVID-19 may be followed by persistent symptoms including fatigue, dyspnea, headache, musculoskeletal symptoms, and pulmonary functional-and radiological abnormalities. However, the impact of COVID-19 on long-term health outcomes remains to be elucidated. Aims: The Precision Medicine for more Oxygen (P4O2) consortium COVID-19 extension aims to identify long COVID patients that are at risk for developing chronic lung disease and furthermore, to identify treatable traits and innovative personalized therapeutic strategies for prevention and treatment. This study aims to describe the study design and first results of the P4O2 COVID-19 cohort. Methods: The P4O2 COVID-19 study is a prospective multicenter cohort study that includes nested personalized counseling intervention trial. Patients, aged 40–65 years, were recruited from outpatient post-COVID clinics from five hospitals in The Netherlands. During study visits at 3–6 and 12–18 months post-COVID-19, data from medical records, pulmonary function tests, chest computed tomography scans and biological samples were collected and questionnaires were administered. Furthermore, exposome data was collected at the patient’s home and state-of-the-art imaging techniques as well as multi-omics analyses will be performed on collected data. Results: 95 long COVID patients were enrolled between May 2021 and September 2022. The current study showed persistence of clinical symptoms and signs of pulmonary function test/radiological abnormalities in post-COVID patients at 3–6 months post-COVID. The most commonly reported symptoms included respiratory symptoms (78.9%), neurological symptoms (68.4%) and fatigue (67.4%). Female sex and infection with the Delta, compared with the Beta, SARS-CoV-2 variant were significantly associated with more persisting symptom categories. Conclusions: The P4O2 COVID-19 study contributes to our understanding of the long-term health impacts of COVID-19. Furthermore, P4O2 COVID-19 can lead to the identification of different phenotypes of long COVID patients, for example those that are at risk for developing chronic lung disease. Understanding the mechanisms behind the different phenotypes and identifying these patients at an early stage can help to develop and optimize prevention and treatment strategies.
- 28 June 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (7) , 1060
Open AccessPrecision Medicine for More Oxygen (P4O2)—Study Design and First Results of the Long COVID-19 Extension
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has led to the death of almost 7 million people, however, with a cumulative incidence of 0.76 billion, most people survive COVID-19. Several studies indicate that the acute phase of COVID-19 may be followed by persistent symptoms including fatigue, dyspnea, headache, musculoskeletal symptoms, and pulmonary functional-and radiological abnormalities. However, the impact of COVID-19 on long-term health outcomes remains to be elucidated. Aims: The Precision Medicine for more Oxygen (P4O2) consortium COVID-19 extension aims to identify long COVID patients that are at risk for developing chronic lung disease and furthermore, to identify treatable traits and innovative personalized therapeutic strategies for prevention and treatment. This study aims to describe the study design and first results of the P4O2 COVID-19 cohort. Methods: The P4O2 COVID-19 study is a prospective multicenter cohort study that includes nested personalized counseling intervention trial. Patients, aged 40–65 years, were recruited from outpatient post-COVID clinics from five hospitals in The Netherlands. During study visits at 3–6 and 12–18 months post-COVID-19, data from medical records, pulmonary function tests, chest computed tomography scans and biological samples were collected and questionnaires were administered. Furthermore, exposome data was collected at the patient’s home and state-of-the-art imaging techniques as well as multi-omics analyses will be performed on collected data. Results: 95 long COVID patients were enrolled between May 2021 and September 2022. The current study showed persistence of clinical symptoms and signs of pulmonary function test/radiological abnormalities in post-COVID patients at 3–6 months post-COVID. The most commonly reported symptoms included respiratory symptoms (78.9%), neurological symptoms (68.4%) and fatigue (67.4%). Female sex and infection with the Delta, compared with the Beta, SARS-CoV-2 variant were significantly associated with more persisting symptom categories. Conclusions: The P4O2 COVID-19 study contributes to our understanding of the long-term health impacts of COVID-19. Furthermore, P4O2 COVID-19 can lead to the identification of different phenotypes of long COVID patients, for example those that are at risk for developing chronic lung disease. Understanding the mechanisms behind the different phenotypes and identifying these patients at an early stage can help to develop and optimize prevention and treatment strategies.